Abstract
Cancer does not represent a single disease. Rather, cancer is a myriad collection of diseases with as many different manifestations as there are tissues and cell types in the human body, involving innumerable endogenous or exogenous carcinogenic agents, and various etiological mechanisms. What all of these disease states share in common are certain biological properties of the cells that compose the tumors, including unregulated (clonal) cell growth, impaired cellular differentiation, invasiveness, and metastatic potential. It is now recognized that cancer, in its simplest form, is a genetic disease, or more precisely, a disease of abnormal gene expression. Recent research efforts have revealed that different forms of cancer share common molecular mechanisms governing uncontrolled cellular proliferation, involving loss, mutation, or dysregulation of genes that positively and negatively regulate cell proliferation, migration, and differentiation (generally classified as protooncogenes and tumor suppressor genes). Essential to any discussion of the molecular mechanisms that govern disease pathogenesis for specific cancers is an appreciation for the distribution of these diseases among world populations, with consideration of specific risk factors and etiologic agents involved in disease causation. This introduction will describe cancer incidence and mortality for the major forms of human cancer, and will briefly review some of the known risk factors and/or causes of these cancers for specific at-risk populations.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hankey, B. F., Gloeckler-Ries, L. A., Miller, B. A., and Kosary, C. L. (1992) Overview. In: Cancer Statistics Review 1973–1989. NIH Publication No. 92–2789, 1. 1–17.
Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. (1999) Cancer statistics, 1999. Ca Cancer J. Clin. 49: 8–31.
Parkin, D. M., Pisani, P., and Ferlay, J. (1999) Global cancer statistics. Ca Cancer J Clin. 49: 33–64.
Newell, G. R., Spitz, M. R., and Sider, J. G. (1989) Cancer and age. Semin. Oncol. 16: 3–9.
Miller, R. A. (1991) Gerontology as oncology. Research on aging as the key to the understanding of cancer. Cancer 68: 2496–2501.
Reis, L. A. G., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., and Edwards, B. K. (eds.) (1999) SEER Cancer Statistics Review, 1973–1996. National Cancer Institute, Bethesda, MD.
Faber, L. P. (1991) Lung cancer. In: Clinical Oncology (Holleb, A. I., Fink, D. J., and Murphy, G. P., eds.), American Cancer Society Inc., Atlanta, pp. 194–212.
Bunn, P. A., Jr. and Minna, J. D. (1985) Paraneoplastic syndromes. In: Principles and Practice of Oncology ( DeVita, V. T., Hellman, S., and Rosenberg, S. A., eds.), J.B. Lippincott, Philadelphia, pp. 1797–1842.
Shopland, D. R., Eyre, H. J., and Pechacek, T. F. (1991) Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States? J. Natl. Cancer Inst. 83: 1142–1148.
Garfinkel, L. and Silverberg, E. (1991) Lung cancer and smoking trends in the United States over the past 25 yr. Ca Cancer J. Clin. 41: 137–145.
Public Health Service (1982) The Health Consequences of Smoking-Cancer: A Report of the Surgeon General. U.S. Department of Health and Human Services, Office on Smoking and Health, Rockville, MD.
Haenszel, W., Loveland, D. B., and Sirken, M. G. (1962) Lung cancer mortality as related to residence and smoking histories: I. White males. J. Natl. Cancer Inst. 28: 947–1001.
Hammond, E. C., Selikoff, I. J., and Seidman, H. (1979) Asbestos exposure., cigarette smoking, and death rates. Ann. NY Acad. Sci. 330: 473–490.
International Agency for Research on Cancer (1980) Report of an IARC working group: An evaluation of chemicals and industrial processes associated with cancer in humans based on human and animal data: IARC Monographs Vols. 1 to 20. Cancer Res. 40: 1–12.
Schoenberg, J. and Klotz, J. (1989) A Case-Control Study of Radon and Lung Cancer among New Jersey Women. New Jersey State Department of Health Technical Report, Phase I, Trenton, NJ.
Blot, W. J., Xu, Z.-Y., Boice, J. D., Jr., Zhao, D.-Z., Stone, B. J., Sun, J, et al. (1990) Indoor radon and lung cancer in China. J. Natl. Cancer Inst. 82: 1025–1030.
Archer, V. E., Gillam, J. D., and Wagoner, J. K. (1976) Respiratory disease mortality among uranium workers. Ann. NY Acad. Sci. 271: 280–293.
Harley, N. H. and Harley, J. H. (1990) Potential lung cancer risk from indoor radon exposure. Ca Cancer J Clin. 40: 265–275.
Kessler, L. A. (1992) Lung and bronchus. ln: Cancer Statistics Review 1973–1989. NIH Publication No. 92–2789, pp. XV. I - 13.
Kent, T. H., Mitros, F. A. (1991) Polyps of the colon and small bowel, polyp syndromes, and the polyp-carcinoma sequence. In: Pathology of the Colon, Small Intestine, and Anus, 2nd ed. ( Norris, H. T., ed.), Churchill Livingstone, New York, pp. 189–224.
Cooper, H. S. (1983) Carcinoma of the colon and rectum. In: Pathology of the Colon, Small Intestine, and Anus, 2nd ed. ( Norris, H. T., ed.), Churchill Livingstone, New York, pp. 225–262.
Spjut, H. J. (1984) Pathology of neoplasms. In: Neoplasms of the Colon, Rectum, and Anus: Mucosal and Epithelial ( Spratt, J. S., ed.), W.B. Saunders, Philadelphia, pp. 159–204.
DiSario, J. A., Burt, R., Kcndrick, M. L., and McWhorter, W. P. (1994) Colorectal cancers of rare histologic types compared with adenocarcinoma. Dis. Colon Rectum 37: 1277–1280.
Kinzler, K. W. and Vogelstein, B. (1998) Colorectal tumors. In: The Genetic Basis of Human Cancer ( Vogelstein, B. and Kinzler, K. W, eds.), McGraw-Hill, New York, pp. 565–587.
Lynch, H. T., Smyrk, T., and Jass, J. R. (1995) Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? Semin. Surg. Oncol. 11: 406–410.
Lynch, H. T., Smyrk, T., and Lynch, J. F. (1996) Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome). Int. J. Cancer 69: 38–43.
Hamilton, S. R. (1985) Colorectal carcinoma in patients with Crohn’s disease. Gastroenterology 89: 398–407.
Armstrong, B. and Doll, R. (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer 15: 617–631.
Pickle, L. W., Greene, M. H., Zeigler, R. G., Toledo, A., Hoover, R., Lynch, H. T., et al. (1984) Colorectal cancer in rural Nebraska. Cancer Res. 44: 363–369.
Willett, W. C., Stampfer, M. J., Colditz, G. A., Rosner, B. A., and Speizer, F. E. (1990) Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med. 323: 1664–1672.
Burkitt, D. P. (1971) Epidemiology of cancer of the colon and rectum. Cancer 28: 3–13.
Bingham, S., Williams, D. R., Cole, T. J., and James, W. P. (1979) Dietary fibre and regional large-bowel cancer mortality in Britain. Br. J. Cancer 40: 456–463.
Martinez, M. E., McPherson, R. S., Annegers, J. F., and Levin, B. (1995) Cigarette smoking and alcohol consumption as risk factors for colorectal adenomatous polyps. J. Natl. Cancer Inst. 87: 274–279.
Giovannucci, E., Rimm, E. B., Ascherio, A., Stampfer, M. J., Colditz, G. A., and Willett, W. C. (1995) Alcohol, low methionine low folate diets, and the risk of colon cancer in men. J. Natl. Cancer Inst. 87: 265–273.
Gloeckler Ries, L. A. (1992) Colon and rectum. In: Cancer Statistics Review 1973–1989. NIH Publication No. 92–2789, pp. VI. 1–2.
Cohen, A. M., Minsky, B. D., and Schilsky, R. L. (1997) Cancer of the colon. In: Cancer: Principles and Practice of Oncology, 5th ed, ( DeVita, V. T., Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 1144–1197.
Berman, C. (1951) Primary Carcinoma ofthe Liver. London, Lewis.
Higginson, J. (1963) The geographical pathology of primary liver cancer. Cancer Res. 23: 1624–1633.
Munoz, N. and Bosch, X. (1987) Epidemiology of hepatocellular carcinoma. In: Neoplasms of the Liver ( Okuda, K. andIshak, K. G., eds.), Springer-Verlag, Tokyo, pp. 3–19.
Munoz, N. and Linsell, A. (1982) Epidemiology of primary liver cancer. In: Epidemiology of Cancer of the Digestive Tract ( Correa, P. and Haenszel, W., eds.), Martinus Nijhoff, The Hague, pp. 161–195.
Okuda, K., Fujimoto, T., Hanai, A., and Urano, Y. (1987) Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 47: 4967–4972.
Stevens, R. G., Merkle, E. J., and Lustbader, E. D. (1984) Age and cohort effects in primary liver cancer. Int. J. Cancer 33: 453–458.
Simonetti, R. G., Camma, C., Fiorello, F., Politi, F., d’Amico, G., and Pagliari, L. (1991) Hepatocellular carcinoma: a worldwide problem and major risk factors. Dig. Dis. Sci. 36: 962–972.
Eagon, P. K., Francavilla, A., Di Leo, A., Elm, M. S., Gennari, L., Mazzaferro, V., et al. (1991) Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver. Dig. Dis. Sci. 36: 1303–1308.
Ohnishi, S., Murakami, T., Moriyama, T., Mitamura, K., and Imawari, M. (1986) Androgen and estrogen receptors in hepatocellular carcinoma and in surrounding non-cancerous liver tissue. Hepatology 3: 440–443.
Carr, B. I. and Van Theil, D. H. (1990) Hormonal manipulation of human hepatocellular carcinoma. J Hepatology 11 :287–289.
Lai, C.-L., Gregory, P. B., Wu, P.-C., Lok, A. S. F., Wong, K.-P., and Ng, M. M. T. (1987) Hepatocellular carcinoma in Chinese males and females: possible causes of the male predominance. Cancer 60: 1107–1110.
Harris, C. C. and Sun, T.-T. (1984) Multifactorial etiology of human liver cancer. Carcinogenesis 5: 697–701.
Edmondson, H. A. and Steiner, P. E. (1954) Primary carcinoma of the liver. a Study of 100 cases among 48,900 necropsies. Cancer 7: 462–503.
Popper, H., Thug, S. N., McMahon, B. J., Lanier, A. P., Hawkins, 1., and Alberts, S. B. (1988) Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan Eskimos. Arch. Pathol. Lab. Med. 112: 498–504.
Unoura, M., Kaneko, S., Matsushita, E., Shimoda, A., Takeuchi, M., Adachi, H., et al. (1993) High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease. Hepato-Gastroenterology 40: 305–310.
Altmann, H. W. (1994) Hepatic neoformations. Pathol. Res. Pract. 190: 513 577.
Johnson, P. J. and Williams, R. (1987) Cirrhosis and the etiology of hepatocellular carcinoma. J. Hepatol. 4: 140–147.
Craig, J. R., Peters, R. L., and Edmondson, H. A. (1988) Tumors of the Liver and Intrahepatic Bile Ducts. Armed Forces Institute of Pathology, Washington, DC.
Tiribelli, C., Melato, M., Croce, L. S., Giarelli, L., Okuda, K., and Ohnishi, K. (1989) Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities in the world: Trieste, Italy and Chiba, Japan. Hepatology 10: 998–1002.
Okuda, K. and Okuda, H. (1999) Primary liver cell carcinoma. In: Oxford Textbook of Clinical Hepatology. 2nd ed. (Bircher, J., Benhamou, J. P., McIntyre, N., Rizzetto, M., andRodes, J., eds.), Oxford University Press, New York, pp. 1491–1530.
Grisham, J. W. (1995) Liver. In: Pathology of Environmental and Occupational Disease ( Craighead, J. E., ed.), Mosby, St. Louis, pp. 491–509.
Grisham, J. W. (1997) Interspec i es comparison of liver carcinogenesis: Implications for cancer risk assessment. Carcinogenesis 18: 59–81.
International Agency for Research on Cancer (1994) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 56, Some Naturally Occurring Substances: Food Items and Constituents, Heterocylic Aromatic Amines and Mycotoxins. IARC Scientific Publications, Lyon, France
International Agency for Research on Cancer (1994) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 58, Aflatoxins. IARC Scientific Publications, Lyon, France.
Linsell, C. A. (1979) Environmental and chemical carcinogens and liver cancer. In: Liver Carcinogenesis ( Lapis, K. and Johannessen, J. V., eds.), Hemisphere Publishing Co., Washington, DC.
Lutwick, L. I. (1979) Relation between aflatoxine and hepatitis B virus and hepatocellular carcinoma. Lancet 1: 755–757.
Beasley, R. P., Hwang, L.-Y., Lin, C. C., and Chien, C.-S. (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 2: 1129–1133.
International Agency for Research on Cancer (1994) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 59, Hepatitis Viruses. IARC Scientific Publications, Lyon, France.
Stroffolini, T., Chiaramonte, M., Tiribelli, C., Villa, E., Simonetti, R. G., Rapicetta, M., et al. (1992) Hepatitis C virus infection, HbsAg carrier state and hepatocellular carcinoma, relative risk and population attributable risk from a case-control study in Italy. J. Hepatol. 16: 360–363.
Benvegnu. L., Fattivich, G., Noventa, F., Tremolada, F., Chemello, L., Cecchetto, A., et al. (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. Cancer 74: 2442–2448.
Okuda, K. (1995) Hepatocellular carcinomas associated with hepatitis B and C virus infections: Are they different? Hepatology 22: 1883–1885.
Henderson, B. E., Preston-Martin, S., Edmondson, H. A., Peters, R. L., and Pike, M. C. (1983) Hepatocellular carcinoma and oral contraceptives. Br. J. Cancer 48: 437–440.
Cox, D. W. (1995) at-Antitrypsin deficiency. In: The Metabolic and Molecular Bases of Inherited Disease, 7th ed. (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds.), McGraw-Hill Inc., New York, pp. 4125–4158.
International Agency for Research on Cancer (1988) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 44, Alcohol Drinking. IARC Scientific Publications, Lyon, France.
Ikeda, K. Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayaman, K., et al. (1993) A multivariant analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18: 47–53.
Nalpas, B., Feitelson, M., Brechot, C., and Rubin, E. (1995) Alcohol, hepatotropic viruses and hepatocellular carcinoma. Alcohol. Clin. Exp. Res. 19: 1089–1095.
Noda, K., Yoshihara, H., Suzuki, K., Yamada, Y., Kasahara, A., Haynashi, N., et al. (1996) Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma: its relationship to alcohol drinking and age of transfusion. Alcohol. Clin. Exp. Res. 20: 95A - 100A.
Lieber, C. S. (1990) Interactions of alcohol and other drugs and nutrients: implication for the therapy of alcoholic liver disease. Drugs 40: 23–44.
Trichopoulos, D., MacMahon, B., Span-os, L., and Merikas, G. (1980) Smoking and hepatitis B-negative hepatocellular carcinoma. J. Natl. Cancer Inst. 65: 111–114.
Chen, C.-J., Liang, K.-Y., Chang, A.-S., Chang, Y.-C., Lu, S.-N., Liaw, Y.-F., et al. (1991) Effects of hepatitis B virus, alcohol drinking, cigarette smoking, and familial tendency on hepatocellular carcinoma. Hepatology 13: 398–406.
Andersson, M. and Storm, H. H. (1992) Cancer incidence among Danish Thoratrast-exposed patients. J. Natl. Cancer Inst. 84: 1318–1325.
Andersson, M., Vyberg, M., Visfeldt, J., Carstensen, B., and Storm, H. H. (1994) Primary liver tumors among Danish patients exposed to Thoratrast. Radiation Res. 137: 262–273.
Vainio, H. and Wilbourn, J. (1993) Cancer etiology: Agents associated with human cancer. Pharmacol. Toxicol. 72:54-SI 1.
Takayasu, K., Wakao, F., Moriyama, N., Muramatsu, Y., Yamazaki, S., Kosuge, T., et al. (1992) Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 16: 906–911.
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334: 693–699.
Iwatsuki, S., Starzl, T. E., Gordon, R. D., Esquivel, C. O., Tzakis, A. G., Makowka, T. L., et al. (1988) Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc. 20 (Suppl. 1): 498–504.
Scharschmidt, B. F. (1984) Human liver transplantation: Analysis of data on 540 patients from four centers. Hepatology 4: 955–1065.
O’Grady, J. G., Poison, R. J., Rolles, K., Caine, R. Y., and Williams, R. (1988) Liver transplantation for malignant disease: Results from 93 consecutive patients. Ann. Surg. 207: 373–379.
Simonetti, R. G., Liberati, A., Angiolini, C., and Pagliaro, L. (1997) Treatment of hepatocellular carcinoma: a systemic review of randomized controlled trials. Ann. Oncol. 8: 117–1136.
Harada, T., Makisaka, Y., Nishimura, H., and Okuda, K. (1978) Complete necrotization of hepatocellular carcinoma by chemotherapy and subsequent intravascular coagulation. Cancer 42: 67–73.
Okuda, K. and Okuda, H. (1999) Primary liver cell carcinoma. In: Oxford Textbook of Clinical Hepatology, 2nd ed. (Bircher, J., Benhamou, J.-P., McIntyre, N., Rizzetto, M., and Rodes, J., eds.), Oxford University Press, New York, pp. 1491–1530.
Matsuzaki, Y., Osuga, T., Saito, Y., Chuganii, Y., Tanaka, N., Shoda, J., et al. (1994) A new, effective, and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterol. 106: 1032–1041.
Marks, R. (1995) An overview of skin cancers: Incidence and causation. Cancer 75: 607–612.
Boring, C. C, Squires, T. S., and Tong, T. (1992) Cancer Statistics 1992. Ca Cancer J. Clin. 42: 19–38.
Friedman, R. J., Rigel, D. S., Berson, D. S., and Rivers, J. (1991) Skin cancer: Basal cell an d squamous cell carcinoma. In: Clinical Oncology ( Holleb, A. I., Fink, D. J., and Murphy, G. P., eds.), American Cancer Society, Atlanta, GA, pp. 290–305.
Singletary, S. E. and Balch, C. M. (1991) Malignant melanoma. In: Clinical Oncology ( Holleb, A. I., Fink, D. J., and Murphy, G. P., eds.), American Cancer Society, Atlanta, GA, pp. 263–270.
Miller, B. A. and Potosky, A. L. (1992) Prostate. In: Cancer Statistic Review, 1973–1989. NIH Publication Number 92–2789, XXII. 1–8.
Littrup, P. J., Lee, F., and Mettlin, C. (1992) Prostate cancer screening: Current trends and future implications. Ca Cancer J. Clin. 42: 198–211.
Kelsey, J. L. and Berkowitz, G. S. (1988) Breast cancer epidemiology. Cancer Res. 48: 5617–5623.
Hsieh, C.-C., Trichopoulos, D., Katsouyanni, K., and Yuasa, S. (1990) Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case-control study. Int. J. Cancer 46: 796–800.
Scanlon, E. F. (1991) Breast cancer. In: Clinical Oncology ( Holleb, A. I., Fink, D. J., and. Murphy, G. P, eds.), American Cancer Society, Atlanta, GA, pp. 177–193.
Kelsey, J. L., Gammon, M. D., and John, E. M. (1993) Reproductive factors and breast cancer. Epidemiol. Rev. 15: 36–47.
Lipworth, L. (1995) Epidemiology of breast cancer. Eur. J. Cancer Prey. 4: 7–30.
Dupont, W. D., Page, D. L. (1985) Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med. 312: 146–151.
Gayther, S. A., Pharoah, P. D., and Ponder, B. A. (1998) The genetics of inherited breast cancer. J. Mammary Gland Biol. Neoplasia 3: 365–376.
Sutcliffe. S., Pharoah, P. D., Easton, D. F., and Ponder, B. A. (2000) Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer. Mt. J. Cancer 87: 110–117.
Madigan, M. P., Zeigler, R. G., Benichou, J., Byrne, C., and Hoover, R. N. 1995 ) Proportion of breast cancers cases in the United States explained by well established risk factors. J. Natl. Cancer Inst. 87: 1681–1685.
Morris, J., Morrow, M., and Norton, L. (1997) Malignant tumors of the breast. In: Cancer: Principles and Practice of Oncology, 5th ed. ( DeVita, V. T., Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 1557–1616.
Pierce, S. M. and Harris, J. R. (1991) The role of radiation therapy in the management of primary breast cancer. Ca Cancer J. Clin. 41: 85–91.
National Cancer Institute Clinical Announcement. (1995) Adjuvant therapy of breast cancer: tamoxifen update. National Institutes of Health, U.S. Department of Health and Human Services, Washington, DC.
Lynch, H. T., Bewtra, C., Lynch, J. F. (1986) Familial ovarian cancer. Clinical nuances. Am. J Med. 81: 1073–1076.
Schildkraut, J. M. and Thompson, W. D. (1988) Familial ovarian cancer: population-based case-control study. Am. J. Epidemiol. 128: 456–466.
Whittemore, A. S., Wu, M. L., Paffenbarger, R. S., Sarles, D. L., Kampert, J. B., Grosser, S., et al. (1989) Epithelial ovarian cancer and the ability to conceive. Cancer Res. 49: 4047–4052.
Piver, M. S., Baker, T. R., Piedmonte, M., and Sandecki, A. M. (1991) Epidemiology and etiliology of ovarian cancer. Semin. Oncol. 18: 177–185.
Gusberg, S. B. and Runowicz, C. D. (1991) Gynecologic cancer. In: Clinical Oncology ( Holleb, A. I., Fink, D. J., and Murphey, G. P., eds.), American Cancer Society, Atlanta, GA, pp. 481–497.
Yancik, R. (1993) Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 71: 517–523.
Rossieg, M. A., Dating, J. R., Weiss, N. S., Moore, D. E., and Self, S. G. (1994) Ovarian tumors in a cohort of infertile women. N. Engl. J Med. 331: 771–776.
Whittemore, A. S. (1994) The risk of ovarian cancer after treatment for infertility. N. Engl. J. Med. 331: 805–806.
Greene, M. H., Clark, J. W., and Blayney, D. W. (1984) The epidemiology of ovarian cancer. Semin. Oncol. 11: 209–226.
Gross, T. P. and Schlesselman, J. J. (1994) The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer. Obstet. Gynecol. 83: 419–424.
Young, R. C., Walton, L. A., Ellenberg, S. S., Homesley, H. D., Wilbanks, G. D., Decker, D. G., et al. (1990) Adjuvant chemotherapy in stage I and stage II epithelial ovarian cancer: Results from two prospective randomized trials. N. Engl. J. Med. 322: 1021–1027.
Ozols, R. F., Schwartz, P. E., and Eifel, P. J. (1997) Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: Cancer: Principles and Practice of Oncology, 5th ed. ( DeVita, V. T., Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 1502–1539.
Austin, A., Delzell, E., and Cole, P. (1988) Benzene and leukemia: a review of the literature and risk assessment. Am. J. Epidemiol. 127: 419–439.
Kojima, S., Matsuyama, T., Sato, T., Horibe, K., Konishi, S., Tsuchida, M., et al. (1990) Down’s syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood 76: 2348–2353.
Feuer, G. and Chen, I. S. Y. (1992) Mechanisms of human T-cell leukemia virus-induced leukemogenesis. Biochim. Biophys. Acta 1114: 223–233.
Pui, C.-H., Raimondi, S. C., Borowitz, M. J., Land, V. J., Behm, F. G., Pullen, D. J., et al. (1993) Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia. J. Clin. Oncol. 11: 1361–1362.
Preston, D. L., Kusumi, S., Tomonaga, M., Izumi, S., Ron, E., Kuramoto, A., et al. (1994) Cancer incidence in atomic bomb survivors. III. Leukemia, lymphoma and multiple myeloma. Radiat. Res. 137: S68 - S97.
Sandler, D. P. (1995) Recent studies in leukemia epidemiology. Curr. Opin. Oncol. 7: 12–18.
Kabat, G. C., Augustine, A., and Herbert, J. R. (1988) Smoking and adult leukemia: a case-control study. J. Clin. Epidemiol. 41: 907–914.
Siegel, M. (1993) Smoking and leukemia: evaluation of a causal hypothesis. Am. J. Epidemiol. 138: 1–9.
Feychting, M. and Ahlbom, A. (1993) Magnetic fields and cancer in children residing near Swedish high-voltage power lines. Am. J. Epidemiol. 138: 467–481.
Hernandez, J. A., Land, K. J., and McKenna, R. W. (1995) Leukemias, myeloma, and other lymphoreticular neoplasms. Cancer 75: 381–394.
Wingo, P. A., Tong, T., and Bolden, S. (1995) Cancer statistics, 1995. Ca Cancer J Clin. 45: 8–30.
Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. (1997) Cancer statistics, 1997. Ca Cancer J. Clin. 47: 5–27.
Greenlee, R. T., Murray, T., Bolden, S., and Wingo, P. A. (2000) Cancer statistics, 2000. Ca Cancer J. Clin. 50: 7–33.
Scheinberg, D. A., Maslak, P., and Weiss, M (1997) Acute leukemias. In: Cancer: Principles and Practice of Oncology, 5th ed. ( DeVita, V. T., Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 2293–2321.
Deisseroth, A. B., Kantarjian, H., Andreeff, M., Talpaz, M., Keating, M. J., Khouri, I., et al. (1997) Chronic leukemias. In: Cancer: Principles and Practice of Oncology, 5th ed. ( DeVita, V. T., Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 2321–2343.
Khouri, I., Sanchez, F. G., and Deisseroth, A. (1997) Molecular biology of the leukemias. In: Cancer: Principles and Practice of Oncology, 5th ed. ( DeVita, V. T., Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 2285–2293.
Brincker, H. (1985) Estimates of overall treatment results in acute non-lymphocytic leukemia based on age-specific rates of incidence and of complete remission. Cancer Treat. Rep. 69: 5–11.
Shipp, M. A., Mauch, P. M., and Harris, N. L. (1997) Non-Hodgkin’s lymphomas. In: Cancer: Principles and Practice of Oncology, 5th ed. ( DeVita, V. T., Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 2165–2220.
DeVita, V. T., Mauch, P. M., and Harris, N. L. (1997) Hodgkin’s disease. In: Cancer: Principles and Practice of Oncology, 5th ed. ( DeVita, V. T., Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott-Raven, Philadelphia, pp. 2242–2283.
Delsol, G. Meggetto, F., Brousett, P., Cohen-Knafo, E., al Saati, T., Rochaix, P., et al. (1993) Relation of follicular dendritic reticular cells to Reed-Sternberg cells of Hodgkin’s disease with emphasis on the expression of CD21q antigen. Am. J. Pathol. 142: 1729–1738.
Connelly, R. R. and Chistene, B. W. (1974) A cohort study of cancer following infectious mononucleosis. Cancer Res. 34: 1172–1178.
Graff, K. S., Simon, R. M., Yankee, R. A., DeVita, V. T., and Rogentine, G. N. (1974) HL-A antigens in Hodgkin’s disease: histopathologic and clinical correlations. J. Natl. Cancer Inst. 52: 1087–1090.
Biggar, R. J., Horm, J., Goedert, J. J., and Melbye, M. (1987) Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am. J. Epidemiol. 126: 578–586.
Robertson, S. J., Lowman, J. T., Grufferman, S., Kostyu, D., van der Horst, C. M., Matthews, T. J., et al. (1987) Familial Hodgkin’s disease: a clinical and laboratory investigation. Cancer 59: 1314–1319.
Specht, L., Carde, P., Mauch, P., Magrini, S. M., and Santarelli, M. T. (1992) Radiotherapy versus combined modality in early stages. Ann. Oncol. 3: 77–81.
Nissen, N. I. and Nordentoft, A. M. (1982) Radiotherapy versus combined modality treatment of stage I and II Hodgkin’s disease. Cancer Treat. Rep. 66: 799–803.
DeVita, V. T., Serpick, A. A., and Carbone, P. P. (1970) Combination chemotherapy in the treatment of advanced Hodgkin’ s disease. Ann. Intern. Med. 73: 881–895.
Klimo, P. and Conners, J. M. (1985) MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin’s disease. J. Clin. Oncol. 3: 1174–1182.
Prosnitz, L. R., Farber, L. R., Scott, J., Bertino, J. R., Fischer, J. J., and Cadman, E. C. (1988) Combine modality therapy for advanced Hodgkin’s disease: a 15-year follow-up data. J. Clin. Oncol. 6: 603–612.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Coleman, W.B., Tsongalis, G.J. (2002). Cancer Epidemiology. In: Coleman, W.B., Tsongalis, G.J. (eds) The Molecular Basis of Human Cancer. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-125-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-59259-125-1_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-107-3
Online ISBN: 978-1-59259-125-1
eBook Packages: Springer Book Archive